|
Astrocytomas |
|
|
|
Fernandez
PM, Zamorano L, Yakar D, Gaspar L, Warmelink C.
Permanent
iodine-125 implants in the up-front treatment of malignant gliomas
Neurosurgery
1995 Mar;36(3):467-73
|
|
Halligan
JB, Stelzer KJ, Rostomily RC, Spence AM, Griffin TW, Berger MS.
Operation
and permanent low activity 125I brachytheraphy for recurrent high-grade
astrocytomas
Int J
Radiat Oncol Biol Phys 1996 Jun 1;35(3):541-7
|
|
Laperriere
NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J, Pintilie M, Bernstein
M
Randomized
study of brachytherapy in the initial management of patients with malignant
astrocytoma
Int
J Radiat Oncol Biol Phys 1998 Jul 15;41(5):1005-11
|
|
Mayr MT,
Crocker IR, Butker EK, Williams H, Cotsonis GA, Olson JJ
Results
of interstitial brachytherapy for malignant brain tumors
Int J Oncol. 2002 Oct; 21(4): 817-23
|
|
|
Glioblastoma |
|
|
|
David
A. Larson, Jeffrey M. Suplica, Susan M. Chang, Kathleen R. Lamborn, Michael
W. McDermott, Penny K. Sneed, Michael D. Prados, William M. Wara, M. Kelly
Nicholas, Mitchel S. Berger
Permanent iodine 125 brachytherapy in patients with
progressive or recurrent glioblastoma multiforme
Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 119 – 126
|
|
Patel
S, Breneman JC, Warnick RE, Albright RE Jr, Tobler WD, van Loveren HR, Tew
JM Jr
Permanent
iodine-125 interstitial implants for the treatment of recurrent glioblastoma
multiforme
Neurosurgery
2000 May;46(5):1123-8
|
|
Wen PY,
Alexander E 3rd, Black PM, Fine HA, Riese N, Levin JM, Coleman CN, Loeffler JS
Long term results
of stereotactic brachytherapy used in the initial treatment of patients with
glioblastomas
Cancer
1994 Jun 15;73(12):3029-36
|
|
|
Gliomas |
|
|
|
Florell
RC, Macdonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH, Cairncross JG
Selection
bias, survival, and brachytherapy for glioma
J
Neurosurg 1992 Feb;76(2):179-83
|
|
|
The Brain Tumor Cooperative Group ; Robert G. Selker,
M.D.; William R. Shapiro, M.D.; Peter Burger, M.D.; Margaret S. Blackwood, M.S.;
Melvin Deutsch, M.D.; Vincent C. Arena, Ph.D.; John C. Van Gilder, M.D.; Julian
Wu, M.D.; Mark G. Malkin, M.D.; John Mealey, Jr., M.D.; John H. Neal, M.D.;
Jeffrey Olson, M.D.; James T. Robertson, M.D.; Gene H. Barnett, M.D.; Stephen
Bloomfield, M.D.; Robert Albright, M.D.; Fred H. Hochberg, M.D.; Emile Hiesiger,
M.D.; Sylvan Green, M.D.
The Brain
Tumor Cooperative Group NIH Trial 87-01: A Randomized Comparison of Surgery,
External Radiotherapy, and Carmustine versus Surgery, Interstitial Radiotherapy
Boost, External Radiation Therapy, and Carmustine
Neurosurgery
2002 Aug;51(2):343-55
 Abstract |
DBLinks | BL
1:2
|
|
Videtic
GM, Gaspar LE, Zamorano L, Fontanesi J, Levin KJ, Kupsky WJ, Tekyi-Mensah S.
Use of
the RTOG recursive partitioning analysis to validate the benefit of iodine-125
implants in the primary treatment of malignant gliomas.
Int J
Radiat Oncol Biol Phys 1999 Oct 1;45(3):687-92
|
|
|
Meningioma |
|
|
|
Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW
Surgical
resection and permanent brachytherapy for recurrent atypical and malignant
meningioma
Neurosurgery.
2004 Jan;54(1):55-64
|
|
|
Metastatic
Tumors
|
|
|
|
|
Dagnew
E, Kanski J, McDermott MW, Sneed PK, McPherson C, Breneman JC, Warnick RE.
Management of newly diagnosed single brain metastasis using resection and
permanent iodine-125 seeds without initial whole-brain radiotherapy: a two
institution experience.
Neurosurg Focus. 2007 Mar
15;22(3):E3.
 PMID:
17608356 [PubMed - as supplied by publisher]
|
|
Rogers LR, Rock JP, Sills AK, Vogelbaum MA, Suh
JH, Ellis TL, Stieber VW, Asher AL, Fraser RW, Billingsley
JS, Lewis P, Schellingerhout D, Shaw EG; Brain
Metastasis Study Group.
Results of a phase II trial of the gliasite
radiation therapy system for the treatment of newly diagnosed, resected single
brain metastases.
J Neurosurg.
2006 Sep;105(3):375-84.
Abstract
|
|
|
|
